NCT01305616 Effect of Yellow-Tinted Intraocular Lens on Standard Automated Perimetry (SAP) and Short-wavelength Automated Perimetry (SWAP) in Patients With and Without Glaucoma Status COMPLETED Phase NA
NCT01298700 Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE4
NCT01287442 Evaluation of Filtering Blebs Using the "Wuerzburg Bleb Classification Score" Compared to Other Clinical Findings, e.g. the Intraocular Pressure (IOP) Status COMPLETED Phase N/A
NCT01284439 Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma Status UNKNOWN Phase NA
NCT01284166 Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Status WITHDRAWN Phase PHASE3
NCT01272102 Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma Status COMPLETED Phase N/A
NCT01266343 Comparison of Anterior Chamber Paracentesis and Conventional Mannitol Infusion in Patients With Primary Acute Angle-closure Glaucoma Status COMPLETED Phase N/A
NCT01263834 Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome Status COMPLETED Phase PHASE2/PHASE3
NCT01263561 Prospective Randomized Study Comparing Ex-PRESS to Trabeculectomy Status COMPLETED Phase NA
NCT01263535 Use of an Ocular Telemetry Sensor in Tafluprost Treated Patients Status TERMINATED Phase PHASE4
NCT01263444 Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy Status COMPLETED Phase PHASE4
NCT01262209 Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients Status COMPLETED Phase NA
NCT01254604 Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002) Status COMPLETED Phase PHASE3
NCT01254370 Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease Status COMPLETED Phase PHASE2